Press Releases
SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D Laboratory
SEQENS, an integrated leader in the manufacturing of active ingredients and pharmaceutical intermediates, announced a multi-million-dollar investment in its research and development laboratory located in Devens, Mass. The improvements will ensure that the new facility will operate at the...
Press Releases
Phlow to Provide Manufacturing R&D Services for Small Molecule Pharmaceutical Product Development in the Commercial Sector
Phlow Corp., a U.S.-based essential medicines public benefit company, announced strategic alliances with both Virginia Commonwealth University’s (VCU) Medicines for All Institute and AMPAC Fine Chemicals to provide contract continuous manufacturing research and development (R&D) services for small molecule...
Press Releases
Sen-Jam Pharm Partners with Specialty Pharma Manufacturer to Provide Formulation and Chemistry, Manufacturing & Controls for Covid-19 Oral Therapeutic
Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories by repurposing existing molecules for novel combination therapy, has entered a strategic partnership with KVK Tech. KVK Tech is a leading Specialty Pharmaceutical Manufacturing company that...
Press Releases
Gamma Biosciences Launches Initiative Through Mirus Bio to Develop Lipid-Polymer Nanocomplexes for In Vivo mRNA Delivery
Gamma Biosciences, a global life sciences company serving the advanced therapy market, announced an initiative through its subsidiary Mirus Bio, a leader in nucleic acid delivery technology, to develop novel, highly active lipid-polymer nanocomplexes for therapeutic mRNA delivery in...
Press Releases
Pfizer to supply UNICEF up to 4 million treatment courses of novel Covid-19 oral treatment, Paxlovid for low- and middle-income countries
Pfizer Inc. announced an agreement with UNICEF to supply up to 4 million treatment courses of its Covid-19 oral treatment, Paxlovid (nirmatrelvir tablets and ritonavir tablets), to 95 low- and middle-income countries, pending authorization or approval. This includes...
Press Releases
Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries
Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, and Biolexis, a division of Stelis Biopharma Limited (Stelis), announced that they have entered into a licensing, manufacturing and commercialization agreement for Akston’s AKS-452, a protein subunit COVID-19...
Press Releases
Peli BioThermal Launches Updated Credo ProEnvision Software
Peli BioThermal, the life science industry’s cold chain partner from discovery to distribution, announces a growing number of enhancements to its CredoProEnvision track and trace software. CredoProEnvision 2.0 lays the groundwork for more significant software updates as Peli BioThermal...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















